Now celebrating its 40th year, the FT Global Pharmaceutical and Biotechnology Conference is the essential annual event for pharma-healthcare professionals keen to explore fresh ideas in areas like drug discovery, clinical trials, market access, manufacturing and supply chains.
The conference will feature an unrivalled line-up of senior public and private sector speakers from all over the world. Together they will share insights on how to reshape product lifecycles through innovation and collaboration, blazing the trail for a new era for healthcare.
Digitally connect with over 2,000 of the most influential players in the global pharma-bio industry
Hear from industry decision-makers as leading pharmaceutical CEOs debate about the effects of Covid-19 online
Built upon a 39-year track record of trusted and successful healthcare conferences
Three days of FT-curated content designed to help re-shape the pharma pipeline for growth
Bringing a unique digital dimension to pharma-bio’s premier industry event
“Great organisation, well thought and engaging event. A must for global healthcare and life science leaders.”
Previous speakers included:
CEO - Healthcare,
President - Oncology,
Executive Vice President - R&D,
Founder, Chairman and CEO,
1000+ Companies represented
300m+ Social media reach